Hetal Sarvaiya

Close out this brand-new seminar day with a panel session of all the day’s speakers. Bring your unanswered questions to explore how to streamline bioanalytical strategy and alignment across ADC development phases, understand the cutting-edge bioanalytical technologies in 2025, and delve into detailed ADC PK/PD investigation to acutely characterize your ADC clinical material

• Evaluating ADC stability and bioanalytical measures from early discovery and throughout development
• Explaining strategy to inform ADC bioanalytical platforms, analytes, and PK assays heading into the clinic
• Striving for collaboration and alignment between regulated and non-regulated ADC bioanalytical teams

Properly understanding ADC PK/PD and in vivo stability is crucial to best inform clinical performance and trial design.

Don’t miss this brand-new seminar day exploring bioanalytical strategy across development phases, insights into LC-MS method development, and in vivo biotransformation impacting PK/PD and stability properties to understand how to efficiently leverage bioanalytical technologies to best characterize your ADC clinical material

Download the Full Event Guide for full details